Life Science Leader I How A New Biopharma CEO Approaches Diversity & Inclusion
- ignacioguerrero-ro
- Mar 19, 2021
- 1 min read
Updated: May 7, 2021
By Rob Wright Michael McCullar, Ph.D., who joined OnQuality Pharmaceuticals as the company’s CEO in Dec. 2020, shares thoughts on his approach to diversity and inclusion (D&I) as a newly appointed leader. The full executive virtual roundtable, “Making Diversity & Inclusion A Best Business Practice,” can be viewed here.
Comentários